Nurse Practitioner, Primary Care · Baltimore, MD
NPI
1063137263
Since 2022
Specialty
Nurse Practitioner, Primary Care
Code 363LP2300X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
345 Saint Paul St
Baltimore, MD, 21202
Phone (410) 332-9000
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
495 services
Medicare patients, 2024
106
Average age 74
Drug cost, 2024
$3.4M
784 prescriptions
Company payments, 2025
$1,307
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Xiaohong N Jiang was code 99214 (office e&m - established), 98 times for 64 patients. In total Xiaohong N Jiang billed 495 services in 13 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 98 | 64 | $84.79 | $8,310 |
| 99214 Office E&M - Established | Facility | 70 | 43 | $64.94 | $4,546 |
By year: 2023 $35K for 623 services; 2024 $28K for 495 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 20 | 15 | $7.61 | $152 |
| 80053 Clinical Chemistry | 16 | 12 | $10.35 | $166 |
Medicare prescription drug claims, 2024
In 2024, the drug Xiaohong N Jiang prescribed most often to Medicare patients was Eliquis (Apixaban), with 57 prescriptions and refills. In total Xiaohong N Jiang wrote 784 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 57 | 102 | 21 | $57K |
| Xarelto Rivaroxaban | 55 | 96 | 12 | $54K |
| Prochlorperazine Maleate Generic | 37 | 37 | 20 | $429 |
| Revlimid Lenalidomide | 33 | 33 | Under 11 | $606K |
| Ondansetron Hcl Generic | 31 | 31 | 20 | $120 |
| Lenalidomide Generic | 29 | 29 | Under 11 | $391K |
| Imbruvica Ibrutinib | 26 | 26 | Under 11 | $418K |
| Pomalyst Pomalidomide | 26 | 26 | Under 11 | $609K |
| Hydroxyurea Generic | 25 | 62 | Under 11 | $415 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 22 | 32 | Under 11 | $73.74 |
| Letrozole Generic | 21 | 63 | Under 11 | $483 |
| Levothyroxine Sodium Generic | 19 | 28 | Under 11 | $137 |
| Xtandi Enzalutamide | 17 | 17 | Under 11 | $240K |
| Acyclovir Generic | 16 | 30 | Under 11 | $344 |
| Tramadol Hcl Generic | 15 | 15 | Under 11 | $27.34 |
Brand drugs: 289 claims; generic drugs: 495 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Xiaohong N Jiang $1,307 ($1,307 in general payments such as food, travel and fees) from 13 companies. The largest payer was Novartis Pharmaceuticals Corporation with $451.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 6 | $451 |
| Daiichi Sankyo Inc. 4568.T | 10 | $289 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $83.46 |
| Janssen Biotech, Inc. JNJ | 2 | $76.13 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $50.55 |
| Caris MPI, Inc. | 2 | $37.25 |
| Exelixis Inc. EXEL | 1 | $32.02 |
| GlaxoSmithKline, LLC. GSK | 1 | $30.35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.